Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Citius Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Citius Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Citius Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2025 was $157,541, a 1971% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Citius Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $157,541 +$149,934 +1971% 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 $173,914 +$161,436 +1294% 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 $191,377 +$172,878 +935% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 $183,345 +$157,714 +615% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 $7,607 -$26,239 -78% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 $12,478 30 Sep 2024 10-K 27 Dec 2024 2024 FY
Q2 2024 $18,499 30 Jun 2024 10-Q 12 Aug 2024 2024 Q3
Q1 2024 $25,631 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $33,846 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.